AT&T spent $3.09M on lobbying in 2nd quarter WASHINGTON — Phone company AT&T Inc. spent $3.09 million in the second quarter to lobby the federal government on a wide array of issues, including retiree health care and taxes on cell phone service, according to a disclosure report. The lobbying amount was up slightly from the [...]
Digimarc reports wider 2Q loss on joint venture BEAVERTON, Ore. — Digimarc Corp., which develops digital watermarking technology for images, reported a wider second-quarter loss on Friday as it booked development costs for joint venture investments with The Nielsen Co. For the quarter that ended June 30, Digimarc lost $896,000, or 13 cents per share, [...]
more images more images Quest Software shares jump after solid 2Q results NEW YORK — Shares of Quest Software Inc. got a boost Friday after the business software maker posted better-than-expected second-quarter results. The company earned $17.4 million, or 19 cents per share, down 15 percent from a profit of $20.5 million, or 21 cents [...]
more images more images Guyana to sell needy 90,000 computers at discount GEORGETOWN, Guyana — Guyana has pledged to spend $30 million in the next three years to buy 90,000 laptops and resell them at a discount to the poor. President Bharrat Jagdeo says the project aims to improve education in poor communities. The South [...]
FBI access to e-mail, Web data raises privacy fear WASHINGTON — Invasion of privacy in the Internet age. Expanding the reach of law enforcement to snoop on e-mail traffic or on Web surfing. Those are among the criticisms being aimed at the FBI as it tries to update a key surveillance law. With its proposed [...]
CV Screen, the reputed UK based IT employment agency reported that there is a sharp rise of registered IT vacancies in Q2, 2010 compared to Q2, 2009. The company witnessed an increase of 47% jobs during Q2 period this year compared to the same period last year. Additionally, the number of candidates per role … [...]
more images more images Cell phone shipments continue to recover NEW YORK — The number of cell phones shipped worldwide rose 14.5 percent in the second quarter compared with a year earlier, with much of the growth coming from smaller challengers like the iPhone and BlackBerry, according to research firm IDC. Manufacturers shipped 317.5 million [...]
Soldier accused of leaking secrets flown to US WASHINGTON — The Army intelligence specialist charged with leaking U.S. military secrets to the WikiLeaks website has been moved from Kuwait to a military jail in Virginia. In a statement Friday, the Army said Pvt. Bradley Manning was flown Thursday to Quantico Marine Base where he will [...]
…. Original article on Gaea Times at : Do you think Oracle will kill Java?.
Doctors have successfully transplanted windpipes into two cancer patients in an innovative procedure that uses stem cells to allow a donated trachea to regenerate tissue and create an organ biologically close to the original.
WASHINGTON, July 30 (UPI) — The Food and Drug Administration has given approval to proceed with the world’s first human clinical trial of a human embryonic stem cell-based therapy. Food and Drug Administration – Stem cell – Clinical trial – Biotechnology – Biology
A trial could offer the first glimpse of a technology that may hold vast medical promise but also is embroiled in controversy.
A therapy for acute spinal cord injuries developed by a UC Irvine scientist will become the world’s first clinical trial of a treatment using human embryonic stem cells. Geron Corp. of Menlo Park announced Friday that the U.S. Food and Drug…
Geron will begin tests of its therapy for spinal cord injury. Advanced Cell Technology hopes to follow with a stem cell treatment for blindness. The Food and Drug Administration has cleared Geron, a stem cell company based in Menlo Park, CA, to move forward with clinical tests of its experimental cell therapy for spinal cord [...]
Geron Corp. said it was cleared by U.S. regulators to proceed with the first human test of an embryonic stem-cell therapy, aimed at patients with spinal-cord injuries. The shares rose 17 percent.
Geron Corp. said U.S. regulators cleared the company to proceed with the first medical trial of embryonic stem-cell treatment in patients with spinal-cord injuries. The shares rose as much as 16 percent.
WASHINGTON The FDA’s blessing Friday of the world’s first clinical trial of a human embryonic stem cell (hESC) therapy has not only launched what may be “the dawn of a new era” for medical treatment, but if successful, the therapies could alleviate much of the burdensome costs plaguing the nation’s health care system, insisted Geron [...]
Geron says FDA will allow embryonic stem cell study; safety concerns caused 11-month delay Stem cell – Embryonic stem cell – Biotechnology – Spinal cord injury – Geron Corporation
Geron Corp. said it has been cleared by regulators to proceed with the first human test of an embryonic stem cell therapy, designed for patients with spinal-cord injuries. The shares rose as much as 16 percent. The Food and Drug Administration lifted a… Food and Drug Administration – Stem cell – Geron Corporation – Spinal [...]
Geron Corp. said today that it hopes to begin within the next two months a clinical trial for an hESC therapy for spinal injuries, triggering a wave of ebullience from scientists, investors and patient advocates. The company disclosed its plans following the lifting by the FDA of a hold on the effort. Clive Cookson of [...]